Erlonat 150 mg Tab(Erlotinib)

Erlonat 150 mg Tab(Erlotinib)

As Erlonat a product by Natco Pharma is tyrosine kinase inhibitor, it kills the affected cancer cells during the process by preventing the growth of them.  This is the reason this tablet is not prescribed for hypersensitive patient or platinum based chemotherapy patient.

Erlonat is administered to the patients who are suffering from lung cancer or metastatic lung cancer which is now at advanced stage. It is also being given to the patients having pancreatic cancer with the combination of other drugs. As this medicine is considered as a tyrosine kinase inhibitor which is usually prescribed for lung cancer. There are some side effects which may turn into a serious if proper prescription is not followed.

Substitute Available

1. Erlotib 150mg Tab(by Intas Pharmaceuticals Ltd.)

2. Erlocip 150mg Tab( Cipla Ltd)